SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer

Condition:   Head and Neck Cancer Intervention:   Genetic: ADP-A2M4 in combination with pembrolizumab. Sponsor:   Adaptimmune Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials